Results 261 to 270 of about 714,773 (317)

A Study of the Serologic Response to Ultraviolet-Formalin Inactivated Poliomyelitis Vaccine

open access: green, 1958
Joseph G. Molner   +4 more
openalex   +1 more source

Topics of Interest in Women With Myeloproliferative Neoplasms

open access: yesAmerican Journal of Hematology, EarlyView.
Women with MPN: life‐cycle phases, specific risks, and influencing factors. ABSTRACT Overview Sex and gender have emerged as central modifiers of disease biology, phenotype, and clinical outcomes in myeloproliferative neoplasms (MPNs). This review will uniquely highlight issues affecting women with MPN and articulate their relevant determinants ...
Natasha Szuber   +2 more
wiley   +1 more source

A study on the variation of cytokine and electrolyte levels in rhesus macaques, cynomolgus monkeys, and Assamese macaques

open access: yesAnimal Models and Experimental Medicine, EarlyView.
This study aims to investigate the variations in cytokine and electrolyte levels among rhesus macaques, cynomolgus monkeys, and assamese macaques in terms of species, sex, and age. By assessing 23 immune function indicators and 5 electrolyte indicators, significant differences in cytokine and electrolyte levels were detected across different monkey ...
Suqin Duan   +12 more
wiley   +1 more source

Development and validation of BCG vaccine‐induced novel granulomatous liver injury preclinical animal model

open access: yesAnimal Models and Experimental Medicine, EarlyView.
The study successfully developed and validated a granulomatous liver injury model using a high‐dose BCG vaccine, simulating hepatic tuberculosis and autoimmune granulomatous liver diseases. Pharmacokinetic analysis examined the metabolic behavior of first‐line antitubercular drugs (isoniazid and rifampicin) and their main metabolites under conditions ...
Swati Sharma   +8 more
wiley   +1 more source

Knowledge, attitudes and barriers to uptake of COVID-19 vaccine in Uganda, February 2021. [PDF]

open access: yesBMJ Glob Health
Amodan BO   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy